Propranolol Hydrochloride is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Bai-Rong Xia (1) and Second Xiangya Hospital of Central South University (1). Registered phases: Phase 2 and Phase 1. Conditions studied include Ovarian Cancer; Non Small Cell Lung Cancer; Propranolol.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07125391 | Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer (ClinicalTrials.gov ↗) Ovarian Cancer |
Phase 2 | Recruiting |
| NCT05979818 | Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer (ClinicalTrials.gov ↗) Non Small Cell Lung Cancer, Propranolol |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Ovarian Cancer | 1 |
| Non Small Cell Lung Cancer | 1 |
| Propranolol | 1 |
| Lead sponsor | Trials |
|---|---|
| Bai-Rong Xia | 1 |
| Second Xiangya Hospital of Central South University | 1 |
| Register | Propranolol Hydrochloride trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Propranolol Hydrochloride works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Propranolol Hydrochloride (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.